Application | Comment | Organism |
---|---|---|
drug development | since vertebrates lack the shikimate pathway for the biosynthesis of aromatic compounds and thus do not possess chorismate mutase activity, the enzyme represents a prime target for the development of antibacterials | Mycobacterium tuberculosis |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
1-isopropyl-2-methoxy-4-methylbenzene | - |
Mycobacterium tuberculosis | |
2-isopropyl-5-methylphenyl acetate | - |
Mycobacterium tuberculosis | |
2-methyl-5-(prop-1-en-2-yl)cyclohexanol | - |
Mycobacterium tuberculosis | |
3-chloroquinoxaline | - |
Mycobacterium tuberculosis | |
3-isopropylphenol | - |
Mycobacterium tuberculosis | |
3-methyl-5-(propan-2-yl)phenol | - |
Mycobacterium tuberculosis | |
4-(3,4-dimethoxyphenethylamino)-3-nitro-5-sulfamoylbenzoic acid | - |
Mycobacterium tuberculosis | |
5-isopropyl-2-methylaniline | - |
Mycobacterium tuberculosis | |
5-naphthyl-7-propyl-3H-pyrazolo[4,3-d][1,2,3]triazin-4(5H)-one | - |
Mycobacterium tuberculosis | |
carvacrol | lead compound | Mycobacterium tuberculosis | |
eugenol | - |
Mycobacterium tuberculosis | |
menthol | - |
Mycobacterium tuberculosis | |
additional information | identification and structure-activity relationship study of carvacrol derivatives as Mycobacterium tuberculosis chorismate mutase inhibitors, structure-based e-pharmacophore modeling, overview. Database screening using the crystal structure of the MTB CM bound transition state intermediate (PDB ID 2FP2) as framework. No inhibition by 3-(6-(benzyloxy)-1H-indol-1-yl)propanoic acid, 5-isopropyl-2-methylphenyl acetate, 4-bromo-5-isopropyl-2-methylphenol, 4-nitro-5-isopropyl-2-methylphenol, 4-isopropyl-2-methoxy-1-methylbenzene, 4-bromo-2-isopropyl-5-methylphenol, 4-nitro-2-isopropyl-5-methylphenol, and 4-chloro-2-isopropyl-5-methylphenol | Mycobacterium tuberculosis | |
N-[(3-(2-amino-3-cyano-2H-benzo[h]chromen-4-y))phenyl]methylidyne]-2-hydroxyethanaminium | - |
Mycobacterium tuberculosis | |
neoisopulegol | - |
Mycobacterium tuberculosis | |
o-Cresol | - |
Mycobacterium tuberculosis | |
p-cymene | - |
Mycobacterium tuberculosis | |
Thymol | - |
Mycobacterium tuberculosis | |
Vanillin | - |
Mycobacterium tuberculosis |
Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|
Chorismate | Mycobacterium tuberculosis | - |
Prephenate | - |
? |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Mycobacterium tuberculosis | P9WIB9 | - |
- |
Reaction | Comment | Organism | Reaction ID |
---|---|---|---|
Chorismate = prephenate | the enzyme catalyzes the conversion of chorismate to prephenate, which is formally a Claisen rearrangement that proceeds via an endo-oxabicyclic transition state with a chair-like geometry | Mycobacterium tuberculosis |
Source Tissue | Comment | Organism | Textmining |
---|
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Chorismate | - |
Mycobacterium tuberculosis | Prephenate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
MTB CM | - |
Mycobacterium tuberculosis |
Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0057 | - |
4-(3,4-dimethoxyphenethylamino)-3-nitro-5-sulfamoylbenzoic acid | pH and temperature not specified in the publication | Mycobacterium tuberculosis |
IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|
0.00106 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | carvacrol | |
0.00408 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-isopropyl-5-methylphenyl acetate | |
0.0116 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | p-cymene | |
0.01363 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 2-methyl-5-(prop-1-en-2-yl)cyclohexanol | |
0.01513 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 5-naphthyl-7-propyl-3H-pyrazolo[4,3-d][1,2,3]triazin-4(5H)-one | |
0.01563 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | N-[(3-(2-amino-3-cyano-2H-benzo[h]chromen-4-y))phenyl]methylidyne]-2-hydroxyethanaminium | |
0.01974 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 3-chloroquinoxaline | |
0.0214 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 3-isopropylphenol | |
0.02158 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 1-isopropyl-2-methoxy-4-methylbenzene | |
0.0231 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | o-Cresol | |
0.0248 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | Vanillin | |
0.02638 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | menthol | |
0.02677 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | 3-methyl-5-(propan-2-yl)phenol | |
0.0284 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | Thymol | |
0.02858 | - |
pH and temperature not specified in the publication | Mycobacterium tuberculosis | eugenol |
General Information | Comment | Organism |
---|---|---|
metabolism | chorismate mutase is located at the branch point of the shikimate pathway and channels chorismate into the Tyr/Phe-specific branch. The enzyme catalyzes the conversion of chorismate to prephenate | Mycobacterium tuberculosis |